Insider Selling: Inotiv, Inc. (NASDAQ:NOTV) CEO Sells $281,216.94 in Stock

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 73,617 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $3.82, for a total value of $281,216.94. Following the sale, the chief executive officer now owns 956,592 shares in the company, valued at approximately $3,654,181.44. The trade was a 7.15 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Robert Jr. Leasure also recently made the following trade(s):

• On Friday, January 31st, Robert Jr. Leasure sold 22,700 shares of Inotiv stock. The stock was sold at an average price of $4.15, for a total value of $94,205.00.

Inotiv Stock Performance

NASDAQ:NOTV opened at $4.06 on Friday. The company has a current ratio of 1.57, a quick ratio of 1.28 and a debt-to-equity ratio of 2.31. The company has a market capitalization of $136.90 million, a P/E ratio of -0.88 and a beta of 3.58. The firm has a 50-day moving average price of $4.33 and a two-hundred day moving average price of $2.96. Inotiv, Inc. has a twelve month low of $1.23 and a twelve month high of $11.42.

Inotiv (NASDAQ:NOTV) last released its quarterly earnings results on Wednesday, February 5th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. As a group, research analysts expect that Inotiv, Inc. will post -0.79 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Inotiv

Institutional investors have recently made changes to their positions in the stock. Nkcfo LLC purchased a new stake in Inotiv during the 4th quarter worth about $476,000. Vantage Point Financial LLC purchased a new stake in shares of Inotiv during the fourth quarter worth about $1,393,000. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of Inotiv by 612.5% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock valued at $527,000 after buying an additional 109,397 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Inotiv by 7.7% in the third quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock valued at $427,000 after buying an additional 18,039 shares during the last quarter. Finally, Calamos Advisors LLC purchased a new position in shares of Inotiv during the fourth quarter valued at approximately $275,000. 18.17% of the stock is owned by institutional investors and hedge funds.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.